Leukemia, Myeloid, Chronic-Phase - 25 Studies Found Withdrawn : Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms : Leukemia, Myeloid, Chronic-Phase : 2012-07-24 Terminated : Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) : Leukemia, Myeloid, Chronic Phase : 2005-07-27 : Drug: Imatinib mesylate Imatinib is packaged in bottles as 100mg and 400mg tablets Completed : Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey : Leukemia, Myeloid, Chronic-Phase (CML-CP) : 2010-08-24 : Drug: Imatinib Drug being observed but not provided Active, not recruiting : Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy : Chronic Phase CML : 2011-10-14 : Behavioral: no access to eMedonline Active, not recruiting : Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib : Chronic Phase Chronic Myeloid Leukemia : 2012-05-04 : Drug: Imatinib Other Names: Not yet recruiting : A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML : Leukemia, Chronic Myeloid : 2016-11-22 : Drug: Nilotinib Nilotinib 300 Active, not recruiting : A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib : Leukemia : 2008-10-21 : Drug: Dasatinib Other Name: Sprycel (BMS-354825) Active, not recruiting : Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients : Chronic Phase Chronic Myeloid Leukemia : 2012-10-03 : Drug: Nilotinib Active, not recruiting : Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) : Leukemia, Myelogenous, Chronic : 2005-08-11 : Drug: Nilotinib 400 mg orally twice daily Other Name Terminated : Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib : Leukemia, Myeloid, Chronic : 2006-05-01 : Drug: Imatinib Imatinib tablet <<< Previous | Next >>>
